In the BioHarmony Drug Report Database

"Preview" Icon

Nonacog alfa

BeneFIX (nonacog alfa) is a protein pharmaceutical. Nonacog alfa was first approved as BeneFIX on 1997-08-27. It is used to treat factor VII deficiency, hemophilia a, hemophilia b, and hypoprothrombinemias in the USA. It has been approved in Europe to treat hemophilia b.

 

Trade Name

 

BeneFIX
 

Common Name

 

nonacog alfa
 

ChEMBL ID

 

CHEMBL2109205
 

Indication

 

factor vii deficiency, hemophilia a, hemophilia b, hypoprothrombinemias
 

Drug Class

 

Image (chem structure or protein)

Nonacog alfa structure rendering